Aytu Biopharma (AYTU) EV to EBITDA (2023 - 2025)
Aytu Biopharma's EV to EBITDA was -3.49 in fiscal Q3 2025 (quarter ended Mar 31, 2025), compared with -0.33 a year earlier.
Powered by 
Analysis
Aytu Biopharma (AYTU) EV to EBITDA (2023 - 2025) Analysis & Trends
On a trailing twelve-month basis, Aytu Biopharma's EV to EBITDA was -23.09 through Mar 31, 2025; for FY2024 (ended Jun 30, 2024), it was -0.50.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -3.60 |
| Sep 30, 2024 | -1.36 |
| Jun 30, 2024 | -0.50 |
| Mar 31, 2024 | -0.35 |
| Dec 31, 2023 | -2.03 |
API Access
Aytu Biopharma EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();